Luxembourg Rudi Balling discusses his distinguished career in the life sciences, the LCSB’s mission, and Luxembourg’s burgeoning reputation as a biomedicine, interdisciplinary research, and scientific innovation hub. Earlier this year you were awarded the ‘Ordre de Mérite’ for your longstanding contribution to science by the Luxembourg government following a distinguished career…
Mexico Dr. David Kershenobich Stalnikowitz, General Director of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán on the myriad issues surrounding diabetes in Mexico and how the Mexican healthcare system can evolve. You have highlighted the importance of the institute operating as a reference center. What have been some…
Ireland In an exclusive interview, Irish Minister for Foreign Affairs and Trade, Charles Flanagan TD, outlines the Department’s enhanced focus on trade and economic recovery, Ireland’s commitment to productive global engagement, and the strategic importance of the life sciences industry to Ireland’s economy. In 2015, the Irish Government launched a…
Singapore Having recently obtained cGMP from Singapore’s Health Sciences Authority, the founders of PrIME Biologics showcase the role of PrIME Technology in driving plasma self-sufficiency in Asia, while highlighting how this innovative technology is disrupting industry standards of plasma fractionation. Could you please introduce to our international readers the background underlying…
Switzerland Kari Sarvanto introduces Primex, an innovative fast-growing company spearheading a new pharmaceutical business model, strongly focusing on anesthesiology. He talks about entrepreneurship, innovation and new ways of achieving success in the pharmaceutical business today. Primex calls itself ‘an innovative and fast-growing company spearheading a new pharmaceutical business model’. What exactly…
Luxembourg The recently appointed managing director of Pfizer Luxembourg discusses the current footprint of the company in the country; how every affiliate within the group counts; market access procedures; and the role of Luxembourg within the life sciences and healthcare sector. Since September 2016, you have been managing director of Pfizer…
Director and senior executive officer of Terumo Corporation and managing director of Terumo Asia Holdings, Hideo Arase recounts key takeaways from working in the US medtech market, the unique M&A opportunities he sees in Asia—especially as a pathway for bridging access to care in developing countries—while highlighting how Terumo can…
Mexico Consuelo Albarrán, co-founder and CEO of DEFI Latina Healthcare, showcases the increasing added value brought by this leading Cofepris-authorized third party (ATP) to the pharmaceutical industry, the recent expansion of the company’s capacity into the biotech field, and its readiness to increase collaboration with both pharma companies and Cofepris to…
Switzerland Gaelle Meaude, operations director of Thea Switzerland, talks about building an effective sales and marketing team over the last few years; why the Swiss preservative-free eye care market remains particularly dynamic; and how working for a French family run entrepreneurial company, with five generations of expertise in the field of…
Paulyn Ubial, Secretary of the Philippines Department of Health, discusses her Department’s work to achieve universal healthcare and expand access to high-quality health services to the entire Filipino population. She also discusses her work to empower women in the country as the founder of the women’s health and development program.…
Switzerland Nicolas Hug reveals how UCB´s new facility in Bulle, Switzerland, is one of the largest microbial derived pharmaceuticals plants in Europe; how the key challenge for manufacturers today is to guarantee supplies by building a robust network; and why manufacturing is where dreams become reality, taking the results from a…
Luxembourg Luxembourg has a young and ambitious life sciences community, which has identified four aspects of personalized medicine where the country has significant potential: digital health, neurodegenerative diseases, molecular diagnostics and immune-oncology. Thomas Dentzer, Head of the Life Sciences sector in Luxembourg, discusses the flexible and supportive atmosphere for companies and…
See our Cookie Privacy Policy Here
